Subclinical Hypothyroidism: behavioral and psychophysiological characteristics.A pilot study

Background: Clinical hypothyroidism affects various aspects of cognitive and affective brain function. The most severe hypothyroidism may also mimic a picture of melancholic depression and dementia. Subclinical hypothyroidism (SHT) is characterized by elevated TSH levels despite normal thyroid hormone concentrations. The aim of this research is to verify the presence of a typical psychophysiological pattern in SHT patients. Methods: Since 1998 fifty patients who underwent surgeries at the Department of Endocrinology, University of Pisa, diagnosed with SHT, were subsequently recruited. Subjects underwent an inspection of the reported symptoms using the Crown & Crisp Experiential Index, and a psychophysiological assessment with a simultaneous recording of the parameters Skin Conductance Level/ Response (SCL/SCR), Surface Frontal Electromyogram (EMG), Peripheral Temperature (PT), Heart Rate (HR). As a control group, fifty subjects without endocrine disorders were subsequently recruited. Results: Data shows little difference in levels in hormonal assays except for TSH. There is also a significant elevation of some of the CCEI subscales: Anxiety, Depression, and Somatic Complaints. At the autonomic level, there is a general pattern of excessive arousal with significant differences in SCL/SCR, HR, and PT. Conclusions: A first data interpretation is that in sub-clinical hypothyroidism, the body tries to support and integrate the general lack of energy with an acceleration of the autonomic activity. This condition of initial arousal could be a useful indicator in order to monitor the treatment course and its effectiveness on the pathological evolution

Frataxin participates to the hypoxia-induced response in tumors

Defective expression of frataxin is responsible for the degenerative disease Friedreich's ataxia. Frataxin is a protein required for cell survival since complete knockout is lethal. Frataxin protects tumor cells against oxidative stress and apoptosis but also acts as a tumor suppressor. The molecular bases of this apparent paradox are missing. We therefore sought to investigate the pathways through which frataxin enhances stress resistance in tumor cells. We found that frataxin expression is upregulated in several tumor cell lines in response to hypoxic stress, a condition often associated with tumor progression. Moreover, frataxin upregulation in response to hypoxia is dependent on hypoxia-inducible factors expression and modulates the activation of the tumor-suppressor p53. Importantly, we show for the first time that frataxin is in fact increased in human tumors in vivo. These results show that frataxin participates to the hypoxia-induced stress response in tumors, thus implying that modulation of its expression could have a critical role in tumor cell survival and/or progression

Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans

Severe mitochondria deficiency leads to a number of devastating degenerative disorders, yet, mild mitochondrial dysfunction in different species, including the nematode Caenorhabditis elegans, can have pro-longevity effects. This apparent paradox indicates that cellular adaptation to partial mitochondrial stress can induce beneficial responses, but how this is achieved is largely unknown. Complete absence of frataxin, the mitochondrial protein defective in patients with Friedreich's ataxia, is lethal in C. elegans, while its partial deficiency extends animal lifespan in a p53 dependent manner. In this paper we provide further insight into frataxin control of C. elegans longevity by showing that a substantial reduction of frataxin protein expression is required to extend lifespan, affect sensory neurons functionality, remodel lipid metabolism and trigger autophagy. We find that Beclin and p53 genes are required to induce autophagy and concurrently reduce lipid storages and extend animal lifespan in response to frataxin suppression. Reciprocally, frataxin expression modulates autophagy in the absence of p53. Human Friedreich ataxia-derived lymphoblasts also display increased autophagy, indicating an evolutionarily conserved response to reduced frataxin expression. In sum, we demonstrate a causal connection between induction of autophagy and lifespan extension following reduced frataxin expression, thus providing the rationale for investigating autophagy in the pathogenesis and treatment of Friedreich's ataxia and possibly other human mitochondria-associated disorders

Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.

The mechanisms by which mitochondrial metabolism supports cancer anabolism remain unclear. Here, we found that genetic and pharmacological inactivation of pyruvate dehydrogenase A1 (PDHA1), a subunit of the pyruvate dehydrogenase complex (PDC), inhibits prostate cancer development in mouse and human xenograft tumor models by affecting lipid biosynthesis. Mechanistically, we show that in prostate cancer, PDC localizes in both the mitochondria and the nucleus. Whereas nuclear PDC controls the expression of sterol regulatory element-binding transcription factor (SREBF)-target genes by mediating histone acetylation, mitochondrial PDC provides cytosolic citrate for lipid synthesis in a coordinated manner, thereby sustaining anabolism. Additionally, we found that PDHA1 and the PDC activator pyruvate dehydrogenase phosphatase 1 (PDP1) are frequently amplified and overexpressed at both the gene and protein levels in prostate tumors. Together, these findings demonstrate that both mitochondrial and nuclear PDC sustain prostate tumorigenesis by controlling lipid biosynthesis, thus suggesting this complex as a potential target for cancer therapy

Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts

Friedreich ataxia (FRDA) is a progressive neurodegenerative disease caused by deficiency of frataxin protein, with the primary sites of pathology being the large sensory neurons of the dorsal root ganglia and the cerebellum. FRDA is also often accompanied by severe cardiomyopathy and diabetes mellitus. Frataxin is important in mitochondrial iron–sulfur cluster (ISC) biogenesis and low-frataxin expression is due to a GAA repeat expansion in intron 1 of the FXN gene. FRDA cells are genomically unstable, with increased levels of reactive oxygen species and sensitivity to oxidative stress. Here we report the identification of elevated levels of DNA double strand breaks (DSBs) in FRDA patient and YG8sR FRDA mouse model fibroblasts compared to normal fibroblasts. Using lentivirus FXN gene delivery to FRDA patient and YG8sR cells, we obtained long-term overexpression of FXN mRNA and frataxin protein levels with reduced DSB levels towards normal. Furthermore, γ-irradiation of FRDA patient and YG8sR cells revealed impaired DSB repair that was recovered on FXN gene transfer. This suggests that frataxin may be involved in DSB repair, either directly by an unknown mechanism, or indirectly via ISC biogenesis for DNA repair enzymes, which may be essential for the prevention of neurodegeneration.Ataxia UK, FARA Australasia and FARA US

Cancer metabolism: current perspectives and future directions

Cellular metabolism influences life and death decisions. An emerging theme in cancer biology is that metabolic regulation is intricately linked to cancer progression. In part, this is due to the fact that proliferation is tightly regulated by availability of nutrients. Mitogenic signals promote nutrient uptake and synthesis of DNA, RNA, proteins and lipids. Therefore, it seems straight-forward that oncogenes, that often promote proliferation, also promote metabolic changes. In this review we summarize our current understanding of how ‘metabolic transformation' is linked to oncogenic transformation, and why inhibition of metabolism may prove a cancer′s ‘Achilles' heel'. On one hand, mutation of metabolic enzymes and metabolic stress sensors confers synthetic lethality with inhibitors of metabolism. On the other hand, hyperactivation of oncogenic pathways makes tumors more susceptible to metabolic inhibition. Conversely, an adequate nutrient supply and active metabolism regulates Bcl-2 family proteins and inhibits susceptibility to apoptosis. Here, we provide an overview of the metabolic pathways that represent anti-cancer targets and the cell death pathways engaged by metabolic inhibitors. Additionally, we will detail the similarities between metabolism of cancer cells and metabolism of proliferating cells

Subclinical Hypothyroidism: behavioral and psychophysiological characteristics.A pilot study

Background: Clinical hypothyroidism affects various aspects of cognitive and affective brain function. The most severe hypothyroidism may also mimic a picture of melancholic depression and dementia. Subclinical hypothyroidism (SHT) is characterized by elevated TSH levels despite normal thyroid hormone concentrations. The aim of this research is to verify the presence of a typical psychophysiological pattern in SHT patients. Methods: Since 1998 fifty patients who underwent surgeries at the Department of Endocrinology, University of Pisa, diagnosed with SHT, were subsequently recruited. Subjects underwent an inspection of the reported symptoms using the Crown & Crisp Experiential Index, and a psychophysiological assessment with a simultaneous recording of the parameters Skin Conductance Level/ Response (SCL/SCR), Surface Frontal Electromyogram (EMG), Peripheral Temperature (PT), Heart Rate (HR). As a control group, fifty subjects without endocrine disorders were subsequently recruited. Results: Data shows little difference in levels in hormonal assays except for TSH. There is also a significant elevation of some of the CCEI subscales: Anxiety, Depression, and Somatic Complaints. At the autonomic level, there is a general pattern of excessive arousal with significant differences in SCL/SCR, HR, and PT. Conclusions: A first data interpretation is that in sub-clinical hypothyroidism, the body tries to support and integrate the general lack of energy with an acceleration of the autonomic activity. This condition of initial arousal could be a useful indicator in order to monitor the treatment course and its effectiveness on the pathological evolution

Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin

The inability to produce normal levels of the mitochondrial protein frataxin causes the hereditary degenerative disorder Friedreich's Ataxia (FRDA), a syndrome characterized by progressive gait instability, cardiomyopathy and high incidence of diabetes. Frataxin is an iron-binding protein involved in the biogenesis of iron-sulfur clusters (ISC), prosthetic groups allowing essential cellular functions such as oxidative phosphorylation, enzyme catalysis and gene regulation. Although several evidence suggest that frataxin acts as an iron-chaperone within the mitochondrial compartment, we have recently demonstrated the existence of a functional extramitochondrial pool of mature frataxin in various human cell types. Here, we show that a similar proteolytic process generates both mature mitochondrial and extramitochondrial frataxin. To address the physiological function of human extramitochondrial frataxin, we searched for ISC-dependent interaction partners. We demonstrate that the extramitochondrial form of frataxin directly interacts with cytosolic aconitase/iron regulatory protein-1 (IRP1), a bifunctional protein alternating between an enzymatic and a RNA-binding function through the 'iron-sulfur switch' mechanism. Importantly, we found that the cytosolic aconitase defect and consequent IRP1 activation occurring in FRDA cells are reversed by the action of extramitochondrial frataxin. These results provide new insight into the control of cytosolic aconitase/IRP1 switch and expand current knowledge about the molecular pathogenesis of FRDA

Free fluoride determination in honey by ion-specific electrode potentiometry: method assessment, validation and application to real unifloral samples

Surprisingly, a reliable method for measuring the concentration of free fluoride ions in honey is still missing from the literature, notwithstanding the generally recognized importance of the analyte and the matrix. To fill this gap, this study proposes and validates a straightforward ion-specific electrode potentiometric method for this task. The method offers very low detection and quantification limits (6.7 μg kg− 1 and 25 μg kg− 1, respectively), good linearity (R2 > 0.994), good sensitivity (typically 55 ± 3 mV for an order of magnitude of concentration) in an unusually low concentration interval (between 0.020 and 1 mg L− 1), and acceptable precision and bias. The method was applied to 30 unifloral (thistle, eucalyptus and strawberry tree) honey samples from Sardinia, Italy. The amount of free fluoride ions found in these honeys appears to be lower than the range usually found in the literature; indeed, early results suggest a possible dependence of the analyte concentration on the honey's botanical origin